Search bioRxiv⌕ Search

Biology subjects

Grisdale, C. J.

Publications and source records attributed to Grisdale, C. J..

3 recordsLinked to original sources

Evaluating Language Models for Biomedical Fact-Checking: A Benchmark Dataset for Cancer Variant Interpretation Verification

Accurate interpretation of genomic variants is critical for precision oncology but remains slow and dependent on specialized expertise. Public knowledgebases such as the Clinical Interpretation of Variants in Cancer (CIViC) help by curating literature-backed variant interpretations in a structured form, yet verification and review have become major bottlenecks. Large language models (LLMs) offer a potential mechanism for accelerating biomedical claim verification, but their rapid turnover, variable availability, and known risks of unsupported reasoning require standardized and reproducible evaluation before integration into curation workflows. To address this, we developed CIViC-Fact, an expert-curated, full-text benchmark and evaluation framework. Domain experts linked structured cancer-variant claims to sentence-level evidence from source publications, including evidence from full-text articles, tables, and non-abstract sections that are commonly omitted from existing biomedical question-answering and scientific fact-checking datasets. Claim-verification reference labels were derived from CIViC records, revision histories and controlled data augmentation. A major finding of CIViC-Fact is that abstracts are insufficient for realistic biomedical claim verification. In the evaluated development subset of text-verifiable entries with full-text access, fewer than 30% could be fully validated from the abstract alone, highlighting the importance of full-text evaluation for biomedical curation. Upon the application of our fact-checking pipeline to newly submitted CIViC entries, after excluding entries requiring supplementary material or images for validation, automated retrieval successfully identified appropriate evidence for most cases (93%), supporting low-incremental-effort evaluation of future systems. Fine-tuning improved agreement with CIViC-Fact reference labels on the static benchmark, but larger general-purpose models performed better on a heterogeneous post-cutoff cohort. These findings support CIViC-Fact primarily as a reproducible framework for comparing evolving retrieval and verification systems rather than as validation of a single deployment-ready model. These findings suggest that, in a rapidly changing model landscape, the durable contribution is not a single optimized model but a reproducible benchmark framework that enables continual testing, model substitution, and lightweight updating through small high-quality few-shot exemplar sets.

bioinformatics↗

Evolution of the open-access CIViC knowledgebase is driven by the needsof the cancer variant interpretation community

CIViC (Clinical Interpretation of Variants in Cancer; civicdb.org) is a crowd-sourced, public domain knowledgebase composed of literature-derived evidence characterizing the clinical utility of cancer variants. As clinical sequencing becomes more prevalent in cancer management, the need for cancer variant interpretation has grown beyond the capability of any single institution. With nearly 300 contributors, CIViC contains peer-reviewed, published literature curated and expert-moderated into structured data units (Evidence Items) that can be accessed globally and in real time, reducing barriers to clinical variant knowledge sharing. We have extended CIViCs functionality to support emergent variant interpretation guidelines, increase interoperability with other variant resources, and promote widespread dissemination of structured curated data. To support the full breadth of variant interpretation from basic to translational, including integration of somatic and germline variant knowledge and inference of drug response, we have enabled curation of three new evidence types (predisposing, oncogenic and functional). The growing CIViC knowledgebase distributes clinically-relevant cancer variant data currently representing >2500 variants in >400 genes from >2800 publications.

genomics↗

A Platform for Oncogenomic Reporting and Interpretation

Manual interpretation of variants remains rate limiting in precision oncology. The increasing scale and complexity of molecular data generated from comprehensive sequencing of cancer samples requires advanced interpretative platforms as precision oncology expands beyond individual patients to entire populations. To address this unmet need, we created the Platform for Oncogenomic Reporting and Interpretation (PORI), comprising an analytic framework created to facilitate the interpretation and reporting of somatic variants in cancer. PORI is unique in its integration of reporting and graph knowledge base tools combined with support for manual curation at the reporting stage. PORI represents one of the first open-source platform alternatives to commercial reporting solutions suitable for comprehensive genomic data sets in precision oncology. We demonstrate the utility of PORI by matching 9,961 TCGA tumours to the graph knowledge base, revealing that 88.2% have at least one potentially targetable alteration, and making available reports describing select individual samples.

bioinformatics↗